Le 7 août/August 2026
The common shares of Biomind Labs Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at <a href="https://thecse.com/">www.thecse.com</a> on the listing date.
Biomind Labs is a clinical-stage biopharmaceutical company focused on transforming breakthroughs in neuroscience and biomedical research into novel pharmaceutical drugs and proprietary nanotechnology-based delivery systems for psychiatric and neurological conditions that affect the Central Nervous System. Leveraging translational neuroscience and formulation science, Biomind aims to optimize the pharmacological profile of key endogenous and naturally derived molecules to address unmet needs in the CNS therapeutics.
__________________________
Les actions ordinaires de Biomind Labs Inc. ont été approuvées pour être cotées à la CSE.
Les documents de cotation et de divulgation seront disponibles sur <a href="https://thecse.com/fr/">www.thecse.com</a> à la date d'inscription.
Biomind Labs est une société biopharmaceutique en phase clinique qui se consacre à la transformation des découvertes en neurosciences et en recherche biomédicale en nouveaux médicaments et systèmes d'administration exclusifs basés sur la nanotechnologie pour les affections psychiatriques et neurologiques touchant le système nerveux central. S'appuyant sur les neurosciences translationnelles et la science de la formulation, Biomind vise à optimiser le profil pharmacologique de molécules endogènes et naturelles clés afin de répondre aux besoins thérapeutiques non satisfaits du SNC.
<div>
<div>
<table border="1" cellspacing="1" cellpadding="1">
<tbody>
<tr>
<td>Issuer/Émetteur :</td>
<td>
Biomind Labs Inc.
</td>
</tr>
<tr>
<td>Security Type/Titre :</td>
<td>Common Shares/Actions ordinaires</td>
</tr>
<tr>
<td>Symbol(s)/Symbole(s) :</td>
<td>BMND</td>
</tr>
<tr>
<td>NV Issuer/Émetteur non Émergent :</td>
<td>No/Non</td>
</tr>
<tr>
<td>Number of securities issued and outstanding/ Titres émis et en circulation :</td>
<td>77 571 773</td>
</tr>
<tr>
<td>Number of Securities reserved for issuance/ Titres réservés pour émission :</td>
<td>6 200 000</td>
</tr>
<tr>
<td>CSE Sector/Catégorie :</td>
<td>Life Sciences/Sciences de la vie</td>
</tr>
<tr>
<td>CUSIP :</td>
<td>090702 10 1</td>
</tr>
<tr>
<td>ISIN :</td>
<td>CA 090702 10 1 2</td>
</tr>
<tr>
<td>Boardlot/Quotité :</td>
<td>TBD</td>
</tr>
<tr>
<td>Trading Currency/Monnaie de négociation :</td>
<td>CDN$/$CDN</td>
</tr>
<tr>
<td>Listing Date/Date de l’inscription :</td>
<td>Le 11 août/August 2026</td>
</tr>
<tr>
<td>Other Exchanges/Autres marches :</td>
<td>N/A</td>
</tr>
<tr>
<td>Fiscal Year end /Clôture de l'exercice financier :</td>
<td>31 décembre/December</td>
</tr>
<tr>
<td>Transfer Agent/Agent des transferts :</td>
<td>Odyssey Trust Company</td>
</tr>
</tbody>
</table>
</div>
</div>
 
The Exchange is accepting Market Maker applications for BMND. Please email: <a href="mailto:Trading@theCSE.com">Trading@theCSE.com</a>.
If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: <a href="mailto:Listings@thecse.com">Listings@thecse.com</a>.
Pour toute question, pour obtenir de l’information supplémentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel à l’adresse: <a href="mailto:Listings@thecse.com">Listings@thecse.com</a>.

2026-0812 - New Listing - Biomind Labs Inc. (BMND)

CSE25™

CSE Composite Index®

In this series, we delve deep into the experiences of CSE listed companies, exploring their past successes and future opportunities.

CSE Issuer Spotlight

**Follow us** for the **latest news** from the CSE

 The CSE provides a modern and efficient alternative for companies looking to access the Canadian public capital markets.

The Canadian Securities Exchange (CSE)

Learn how we streamline issuer regulation through enhanced disclosure, practical and effective regulatory oversight, and modern technology.

Listing on the CSE

Learn more about the companies we list and how to get started trading on the CSE.

Investing in Listed Companies

Learn how we lower costs, reduce complexity, and provide market making opportunities for the dealer community.

Trading on the CSE

Whether you’re an investor, business leader, or simply looking to learn more, start your journey with the CSE here.

Get Started

From announcements and market updates to in-depth interviews with company leaders - stay informed with the latest from the CSE.

Latest from the CSE

Discover newly listed companies on the CSE through our series of bite-sized interviews with company leaders.

Get to know our latest listings

Listed Company News

Market Activity

List with the CSE

Find a home for your next big idea.

Frequently Asked Questions

How does being listed on the CSE affect me as a shareholder?

Where do I get information and trade CSE listed securities?

Where can I find an RSS feed for listed company news?

Where is the CSE recognized?

Upcoming Events

join the list

Join our mailing list to receive buy-in notifications

The CSE provides a superior exchange experience by investing in our customers’ success with innovation, dedication, and passion.

Where innovation, passion, and trust intersect

We strive to be the most innovative exchange in Canada. We aim to offer unlimited global access and a customized client-centric experience while delivering the lowest cost of public capital. 

We are Canada's entrepreneurial exchange

Recent Quotes

Get the latest regulatory announcements from the CSE concerning its Listings Policies, Trading Rules and functionality and other important industry developments.

Notices

Get the latest information about new CSE listings, the appointment of Market Makers, market events, and other news.

Bulletins

Stay informed with CSE listed company news, providing transparency and accountability to shareholders and the public.

Company News

Stay Informed

The **total volume** traded on the CSE today is

Connect with our professionals and listing experts at industry events and conferences.